<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 26, 2000
Medical Resources, Inc.
(Exact Name of Registrant as Specified in its Charter)
Commission File No. 0-20440
Delaware 13-3584552
(State of Incorporation) (IRS Employer Identification No.)
125 State Street, Suite 200, Hackensack, NJ 07601
(Address of Principal Executive Office) (Zip Code)
Registrant's Telephone Number, Including Area Code: (201) 488-6230
<PAGE>
Item 4. Changes in Registrant's Certifying Accountant
On October 26, 2000, Medical Resources, Inc. (the "Company") dismissed its
independent auditors, Ernst & Young, LLP and appointed Arthur Andersen, LLP as
the Company's new independent accountants effective October 27, 2000. The
decision to change accountants was recommended and approved by the Company's
Audit Committee.
The reports of Ernst and Young, LLP on the Company's financial statements
for the past two (2) years did not contain an adverse opinion or disclaimer of
opinion, nor was it otherwise qualified or modified as to uncertainty, audit
scope or accounting principles, except that Ernst & Young, LLP's report was
modified relative to the uncertainty of the Company's ability to continue as a
going concern.
During the Company's two (2) most recent fiscal years and any subsequent
interim period preceding the change in accountants, there were no disagreements
with the Company's former accountants on any matter of accounting principles or
practices, financial statement disclosure, or auditing scope or procedure, which
disagreements, if not resolved to the satisfaction of the former accountants,
would have caused them to make a reference to the subject matter of such
disagreements in connection with their reports.
The Company has provided a copy of the disclosures contained herein to
Ernst & Young, LLP and have requested them to furnish the Company with a letter,
addressed to the Commission, stating whether the accountants agree or disagree
with the statements made by the Company. The letter is filed as an Exhibit to
this Form 8-K in accordance with paragraph (a) (3) of Item 304 of Regulation
S-K.
Prior to the engagement of Arthur Andersen, LLP on October 27, 2000, during
the Company's two (2) most recent fiscal years and during any subsequent interim
period, neither the Company nor anyone on its behalf has consulted the Company's
newly engaged accountants regarding either the application of accounting
principles to a specific transaction, whether completed or proposed, or the type
of audit opinion that might be rendered on the Company's financial statements,
and neither a written report or oral advice was provided to the Company that the
new accountants concluded was an important factor considered by the Company in
reaching a decision as to the accounting, auditing or financial reporting issue.
Item 7. Exhibits
16.1 Letter from Ernst & Young LLP, dated October 31, 2000
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Medical Resources Inc.
Date: November 1, 2000 By: /s/ Christopher J. Joyce
------------------------------
Name: Christopher J. Joyce
Title: Co-Chief Executive Officer
<PAGE>
EXHIBIT INDEX
Item No. Description
-------- -----------
16.1 E&Y letter.
